Cargando…

The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data

BACKGROUND: This paper reports the duration of moderate and severe exacerbations in patients with house dust mite induced allergic asthma and the impact on patients’ quality of life. METHODS: Post-hoc analyses were conducted using data collected during a phase III multi-national trial (MT-04) that i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Briggs, Andrew, Nasser, Shuaib, Hammerby, Eva, Buchs, Sarah, Virchow, J. Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803866/ https://www.ncbi.nlm.nih.gov/pubmed/33438083 http://dx.doi.org/10.1186/s41687-020-00274-x

Ejemplares similares

Temperature-controlled Laminar Airflow (TLA) in symptomatic severe asthma – a post hoc analysis of severe exacerbations, quality of life and health economics
por: Chauhan, A. J., et al.
Publicado: (2022)

Normalisation of airflow limitation in asthma: Post‐hoc analyses of TRIMARAN and TRIGGER
por: Papi, Alberto, et al.
Publicado: (2022)

Early Exacerbation Relapse is Increased in Patients with Asthma and Bronchiectasis (a Post hoc Analysis)
por: Hill, Andrew R., et al.
Publicado: (2023)

The use of β(2)-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis
por: Patel, Mitesh, et al.
Publicado: (2015)

A post hoc analysis on the effects of a probiotic mixture on asthma exacerbation frequency in schoolchildren
por: Drago, Lorenzo, et al.
Publicado: (2022)

Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a post-hoc analysis of a randomised phase III study()
por: Li, Jing, et al.
Publicado: (2020)

Correlation between asthma control and quality of life in patients with moderate and severe asthma
por: Valory, Mary Jane Lisboa, et al.
Publicado: (2015)

Antitussive Use in Patients with Inadequately Controlled Moderate-to-Severe Asthma: A Post Hoc Analysis of the Omalizumab EXTRA Trial
por: Rutland, Cedric J, et al.
Publicado: (2023)

Quality of life outcomes in adults with moderate‐to‐severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study
por: van de Kerkhof, P.C.M., et al.
Publicado: (2019)

BiPAP for treating moderate and severe asthma exacerbations in a PED
por: Williams, A, et al.
Publicado: (2013)

Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort
por: de Boer, Geertje, et al.
Publicado: (2021)

Monitoring asthma in childhood: symptoms, exacerbations and quality of life
por: Brand, Paul L.P., et al.
Publicado: (2015)

Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study
por: Corren, Jonathan, et al.
Publicado: (2021)

Severe and Moderate Asthma Exacerbations in Asthmatic Children and Exposure to Ambient Air Pollutants
por: Tétreault, Louis-Francois, et al.
Publicado: (2016)

Predictive factors for moderate or severe exacerbations in asthma patients receiving outpatient care
por: Gutiérrez, Francisco Javier Álvarez, et al.
Publicado: (2017)

Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma
por: Corren, Jonathan, et al.
Publicado: (2021)

Impact of Baseline Lung Function on Future Exacerbations in Patients with Moderate-to-Severe Asthma
por: Khan, Asif H, et al.
Publicado: (2022)

Asthma control and severe exacerbations in patients with moderate or severe asthma in Jilin Province, China: a multicenter cross-sectional survey
por: Yan, Bing-di, et al.
Publicado: (2016)

Role of Intravenous Magnesium in the Management of Moderate to Severe Exacerbation of Asthma: A Literature Review
por: Bokhari, Syed A, et al.
Publicado: (2022)

Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J)
por: Honma, Masaru, et al.
Publicado: (2020)

Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma
por: Papi, Alberto, et al.
Publicado: (2022)

Determining the minimal important differences in the RQLQ score with grass and tree allergy immunotherapy versus placebo in adults with moderate‐to‐severe allergy
por: Blaiss, Michael S., et al.
Publicado: (2022)

Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab
por: Menzies-Gow, Andrew, et al.
Publicado: (2022)

Effect of High Dose Inhaled Glucocorticoids on Quality of Life in Patients with Moderate to Severe Asthma
por: Choi, Jae-Sung, et al.
Publicado: (2005)

A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
por: Andreas, Stefan, et al.
Publicado: (2020)

Omalizumab and quality of life in nasal polyps: A post hoc analysis
por: Han, Joseph K., et al.
Publicado: (2022)

Severe asthma and quality of life
por: Hossny, Elham, et al.
Publicado: (2017)

Gender differences in asthma perception and its impact on quality of life: a post hoc analysis of the PROXIMA (Patient Reported Outcomes and Xolair(®) In the Management of Asthma) study
por: Colombo, Delia, et al.
Publicado: (2019)

COVID‐19 in a patient with severe asthma treated with Omalizumab
por: Lommatzsch, Marek, et al.
Publicado: (2020)

Impact of asthma severity as risk factor to future exacerbations in patients admitted for asthma exacerbation
por: Nakwan, Narongwit
Publicado: (2021)

Severe tracheobronchomalacia misdiagnosed as an asthma exacerbation
por: Alaws, Hossny, et al.
Publicado: (2023)

Herbal Medicine Cordyceps sinensis Improves Health-Related Quality of Life in Moderate-to-Severe Asthma
por: Wang, Ningqun, et al.
Publicado: (2016)

Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial
por: van der Meer, Akke-Nynke, et al.
Publicado: (2021)

The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care Patients
por: Kritikos, Vicky, et al.
Publicado: (2020)

Long‐term, durable, absolute Psoriasis Area and Severity Index and health‐related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate‐to‐severe plaque psoriasis
por: Gooderham, M., et al.
Publicado: (2022)

Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study
por: Li, Jing, et al.
Publicado: (2016)

Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial
por: Watz, Henrik, et al.
Publicado: (2018)

Disconnect for Tezepelumab on Exacerbations, Symptoms, and Quality of Life in Type 2 Low Asthma
por: Lipworth, Brian, et al.
Publicado: (2023)

Omalizumab Effectiveness in Severe Allergic Asthma with Multiple Allergic Comorbidities: A Post-Hoc Analysis of the STELLAIR Study
por: Just, Jocelyne, et al.
Publicado: (2021)

Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis
por: Caruso, Cristiano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0nn1abc9s0e5532rmfsg8iro9e